| Financial Year |
March 31 2023 |
| Monetary Funds |
284,857,818.80 |
| Held-for-trading Financial Assets |
1,258,324,769.97 |
| Notes Receivable |
-- |
| Accounts Receivable |
283,966,679.27 |
| Advances to Suppliers |
74,855,930.61 |
| Other Receivables |
6,270,245.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
205,113,264.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,945,475.82 |
| Total Current Assets |
2,213,744,008.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
761,969,076.37 |
| Investment Properties |
-- |
| Fixed Assetes |
201,794,702.00 |
| Under-construction Projects |
70,895,946.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,892,302.75 |
| R&D expenses |
-- |
| Goodwill |
7,103,962.95 |
| Long-Term Deferred and Prepaid Expenses |
153,564,147.17 |
| Deferred Income Tax Assets |
18,782,703.44 |
| Other Non-Current Assets |
10,706,801.12 |
| Sub-Total of Non-Current Assets |
1,535,123,711.01 |
| Total Assets |
3,748,867,719.14 |
| Short-Term Loans |
66,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,346,531.45 |
| Accounts Payable |
144,048,930.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,433,315.07 |
| Taxes Payable |
28,847,742.19 |
| Interest Payable |
223,243.06 |
| Dividend Payable |
-- |
| Other payables |
115,877,750.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,020,112.75 |
| Other Current Liabilities |
5,325,421.68 |
| Sub-Total of Current Liabilities |
430,102,139.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,824,347.74 |
| Deferred Income Tax Liabilities |
17,322,843.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,056,898.07 |
| Total Liabilities |
489,159,037.65 |
| Paid-In Capital(Or Share Stock) |
259,655,203.00 |
| Capital Surplus |
626,393,479.47 |
| Surplus Reserve |
122,696,784.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,144,191,740.21 |
| Minority Stockholder's Interest |
105,794,399.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,153,914,282.26 |
| Owner's Equity（Stockholder's Equity） |
3,259,708,681.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,748,867,719.14 |
